BCL2 and Miyoshi myopathy: Additional deregulations were then described such as 1q amplification leading to Mcl-1 overexpression in MM (8), Bim deletion in lymphoma cell lines (9) or miRNA deregulation leading to Bcl-2 overexpression in CLL (10, 11).